AAAAAA

   
Results: 1-13 |
Results: 13
RET/PTC1 oncogene signaling in PCCl 3 thyroid cells requires the small GTP-binding protein Rho
Authors: Barone, MV Sepe, L Melillo, RM Mineo, A Santelli, G Monaco, C Castellone, MD Tramontano, D Fusco, A Santoro, M
Citation: Mv. Barone et al., RET/PTC1 oncogene signaling in PCCl 3 thyroid cells requires the small GTP-binding protein Rho, ONCOGENE, 20(48), 2001, pp. 6973-6982
The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret
Authors: Melillo, RM Carlomagno, F De Vita, G Formisano, P Vecchio, G Fusco, A Billaud, M Santoro, M
Citation: Rm. Melillo et al., The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret, ONCOGENE, 20(2), 2001, pp. 209-218
Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation
Authors: Melillo, RM Pierantoni, GM Scala, S Batista, S Fedele, M Stella, A De Biasio, MC Chiappetta, G Fidanza, V Condorelli, G Santoro, M Croce, CM Viglietto, G Fusco, A
Citation: Rm. Melillo et al., Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation, MOL CELL B, 21(7), 2001, pp. 2485-2495
Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade
Authors: Melillo, RM Santoro, M Ong, SH Billaud, M Fusco, A Hadari, YR Schlessinger, J Lax, I
Citation: Rm. Melillo et al., Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade, MOL CELL B, 21(13), 2001, pp. 4177-4187
Increased in vivo phosphorylation of Ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B
Authors: Salvatore, D Melillo, RM Monaco, C Visconti, R Fenzi, G Vecchio, G Fusco, A Santoro, M
Citation: D. Salvatore et al., Increased in vivo phosphorylation of Ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B, CANCER RES, 61(4), 2001, pp. 1426-1431
Glial cell line-derived neutrotrophic factor and neurturin can act as paracrine growth factors stimulating DNA synthesis of Ret-expressing spermatogonia
Authors: Viglietto, G Dolci, S Bruni, P Baldassarre, G Chiariotti, L Melillo, RM Salvatore, G Chiappetta, G Sferratore, F Fusco, A Santoro, M
Citation: G. Viglietto et al., Glial cell line-derived neutrotrophic factor and neurturin can act as paracrine growth factors stimulating DNA synthesis of Ret-expressing spermatogonia, INT J ONCOL, 16(4), 2000, pp. 689-694
Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in RET and RET-derived oncoproteins
Authors: Salvatore, D Barone, MV Salvatore, G Melillo, RM Chiappetta, G Mineo, A Fenzi, G Vecchio, G Fusco, A Santoro, M
Citation: D. Salvatore et al., Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in RET and RET-derived oncoproteins, J CLIN END, 85(10), 2000, pp. 3898-3907
Pivotal role of the RB family proteins in in vitro thyroid cell transformation
Authors: Iuliano, R Trapasso, F Stella, A Le Pera, I Melillo, RM Bruni, P Baldassarre, G Chiariotti, L Santoro, M Viglietto, G Fusco, A
Citation: R. Iuliano et al., Pivotal role of the RB family proteins in in vitro thyroid cell transformation, EXP CELL RE, 260(2), 2000, pp. 257-267
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival
Authors: De Vita, G Melillo, RM Carlomagno, F Visconti, R Castellone, MD Bellacosa, A Billaud, M Fusco, A Tsichlis, PN Santoro, M
Citation: G. De Vita et al., Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival, CANCER RES, 60(14), 2000, pp. 3727-3731
Human N-ras, TRK-T1, and RET/PTC3. oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cells
Authors: Portella, G Vitagliano, D Borselli, C Melillo, RM Salvatore, D Rothstein, JL Vecchio, G Fusco, A Santoro, M
Citation: G. Portella et al., Human N-ras, TRK-T1, and RET/PTC3. oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cells, ONCOL RES, 11(9), 1999, pp. 421-427
Molecular mechanisms of RET activation in human neoplasia
Authors: Santoro, W Carlomagno, F Melillo, RM Billaud, W Vecchio, G Fusco, A
Citation: W. Santoro et al., Molecular mechanisms of RET activation in human neoplasia, J ENDOC INV, 22(10), 1999, pp. 811-819
Different mutations of the RET gene cause different human tumoral diseases
Authors: Santoro, M Melillo, RM Carlomagno, F Visconti, R De Vita, G Salvatore, G Fusco, A Vecchio, G
Citation: M. Santoro et al., Different mutations of the RET gene cause different human tumoral diseases, BIOCHIMIE, 81(4), 1999, pp. 397-402
Ret-mediated mitogenesis requires Src kinase activity
Authors: Melillo, RM Barone, MV Lupoli, G Cirafici, AM Carlomagno, F Visconti, R Matoskova, B Di Fiore, PP Vecchio, G Fusco, A Santoro, M
Citation: Rm. Melillo et al., Ret-mediated mitogenesis requires Src kinase activity, CANCER RES, 59(5), 1999, pp. 1120-1126
Risultati: 1-13 |